Abstract. Myogenic cells provide excellent in vitro models for studying the cell growth and differentiation. In this study we report that lysophosphatidic acid (LPA), a bioactive phospholipid contained in serum, stimulates the growth and inhibits the differentiation of mouse C2C12 myoblast cells, in a distinct manner from basic fibroblast growth factor (bFGF) whose mitotic and anti-differentiation actions have been well investigated. These actions of LPA were both blocked by pertussis toxin, suggesting the involvement of Gi class of G proteins, whereas bFGF acts through receptor tyrosine kinases.
T HE growth and differentiation of cells in organisms are subject to tightly concerted regulation that has long been a major focus of interest. Myogenic cell lines provide excellent in vitro models for studying the control of growth and differentiation mainly for two reasons. First, their growth and differentiation are easily controlled by manipulating the culture medium components (for review see Florini et al., 1991) . Second, the MyoD family of basic helix-loop-helix (bHLH) 1 factors, which play essential roles in myogenic differentiation, have been cloned and well characterized (for reviews see Weintraub et al., 1991; Buckingham, 1992; Olson, 1992; Weintraub, 1993) : these consist of MyoD (Davis et al., 1987) , myoge-1. Abbreviations used in this paper: BrdU, bromodeoxyuridine; CK, creatine kinase; bHLH, basic helix-loop-helix; ITS, DMEM containing insulin, transferrin and sodium selenite; LPA, lysophosphatidic acid; MCK, muscle creatine kinase; PPP, platelet poor plasma-derived serum; PT, pertussis toxin.
nin (Wright et al., 1989) , myf-5 (Braun et al., 1989) , and MRF-4/myf-6/herculin (Rhodes and Konieczney, 1989; Braun et al., 1990; Miner and Wold, 1990) .
Serum and certain fibroblast growth factors (FGFs) are able to stimulate the growth and prevent the terminal differentiation of a number of established myoblast cell lines (Clegg et al., 1987; Lathrop et al., 1985; Spizz et al., 1986) . FGFs (mainly basic [b-] or acidic [a-] FGF) are the most investigated and the most characterized compounds that possess these activities (Florini et al., 1991) . Other than FGFs, epidermal growth factor (EGF) and thrombin have been described to have these effects on a particular cell line, BC3H1, but detailed analyses have not yet been done (Wang and Rubenstein, 1988; Kelvin et al., 1989b) .
Several findings indicate that serum regulates myoblast growth and differentiation by mechanisms independent of bFGF. A rat myoblast line, L6 (Yaffe, 1968) , grows under high serum conditions, but does not respond to FGF. In addition, the serum activities are blocked by pertussis toxin (PT), which specifically inhibits the Gi class of G proteins (Kelvin et al., 1989a,b; Salminen et al., 1991) , while FGF signals, which are transduced through receptor tyrosine kinases (RTK), are unaffected by PT (Fantl et al., 1993; Jaye et al., 1992; Burgess and Maciag, 1989) . Indeed, the FGF family of proteins have a strong affinity for the extracellular matrix and their contents in serum is very low (Klangsbrun and Baird, 1991; Burgess and Maciag, 1989) .
Lysophosphatidic acid (LPA) is a phospholipid contained in serum (Gerrard and Robinson, 1989; Eichholtz et al., 1993) , and has been revealed to elicit a variety of biological responses on a wide range of cells and organisms, including the stimulation of fibroblast proliferation (for reviews see Moolenaar, 1994 Moolenaar, , 1995 . It functions by activating a number of intracellular signal transduction systems through putative cell surface receptor(s) coupled to G-proteins (van Corven et al., 1989 (van Corven et al., , 1992 Jalink et al., 1990; van der Bend et al., 1992a; Thomson et al., 1994) .
In this study, we report that LPA stimulates the growth and inhibits the differentiation of mouse C2C12 myoblast cells in a PT-sensitive manner. Detailed analyses in this study demonstrated that LPA and bFGF act on C2C12 cells by distinct mechanisms. In contrast to bFGF, which stimulated proliferation of undifferentiated myoblasts by repressing MyoD, as previously reported (Vaidya et al., 1989) , LPA did so with MyoD expression maintained. In confluent cultures, while LPA could not inhibit the cellcell contact-induced differentiation, bFGF strongly inhibited this process. In addition, LPA and bFGF acted cooperatively, suggesting that they stimulated different intracellular signaling pathways. This study illustrates distinct roles of Gi-and RTK-mediated signaling pathways in proliferating myoblasts.
Materials and Methods

Cells and Cultivations
The C2C12 mouse myoblast cell line (Yaffe and Saxel, 1977; Blau et al., 1983) was obtained from the Amer. Type Culture Collection (Rockville, MD). A subclone of C2C12 was obtained by limiting dilution for use in this study. C2C12 cells were maintained in DMEM supplemented with 10% FCS and kanamycin (60 p~g/ml). To induce differentiation or to test the effects of the experimental reagents, the cells were cultured on collagen-coated tissue culture plates (Corning, NY/Iwaki, Tokyo, Japan), and then switched to a serum-free ITS medium, consisting of DMEM supplemented with insulin (10 p,g/ml), transferrin (5 p,g/ml), sodium selenite (10 nmol), and bovine serum albumin (BSA, 1 mg/ml). BSA was added to prevent the precipitation of LPA in the presence of calcium ion (Jalink et al., 1990) .
Reagents
FCS and platelet poor plasma-derived serum were purchased from Moregate Gr. Co. (Melbourne, Australia) and Biomedical Technologies Inc. (Stoughton, MA), respectively. Insulin (human), transferrin (human), and BSA were purchased from Sigma Chem. Co (St. Louis, MO). All lipids including LPA (synthesized L-ct-monooleoyl phosphatidic acid) were also purchased from Sigma. bFGF (human, recombinant) were from GIBCO BRL (Gaithersburg, MD) and Pertussis Toxin was from Kaken Pharmacology Co (Chiba, Japan). Anti-MyoD (5.8A), anti-Myogenin (F5D), and anti-Troponin T (NT302) monoclonal antibodies were kindly provided by Drs. P. Houghton (Dias et al., 1992) , W. Wright (Wright et al., 1991) , and T. Obinata (Abe et al., 1986) , respectively.
Fusion Index~Nuclear Number Determination and
BrdU Incorporation
C2C12 cell cultures were fixed and dehydrated with methanol at room temperature for 10 miu, and then stained with Giemsa and Wright solutions (E. Merck, Darmstadt, Germany). The number of nuclei in mononucleated cells and in myotubes, defined as syncytia containing three or more nuclei, were counted using an optical microscope at a magnification of 100x or 200x. Three independent fields of 1 mm 2 were counted to calculate the total number of nuclei per square millimeter and the fusion index (percent of total nuclei incorporated in myotubes). BrdU incorporation was assayed using a Cell Proliferation Kit (Amersham Corp., Arlington Heights, IL). Cells were labeled with BrdU for 4 h followed by immediate fixation with acid ethanol. BrdU incorporated into DNA was visualized by indirect enzymatic immunocytostaining and counterstaining with methyl green.
Immunostaining
Cultured cells were fixed with 2% paraformaldehyde in phosphate-buffered saline at room temperature for 10 min. They were then permeabilized by 0.25% Triton X-100 (room temperature, 20 min) and reacted with the first antibody (4°C, overnight). After incubation with the second antibody (FITC-conjugated anti-mouse IgG), the cells were washed, DNA stained with 4, 6,-diamidino-2-phenylindole (DAPI), and observed under a fluorescent microscopy. In some cases, biotinylated anti-mouse IgG was used as the second antibody followed by visualization using a Vecstain ABC detection kit (Vector Labs., Burlingame, CA).
RNA Analysis
Poly (A) RNA was isolated from the cells using a QuickPrep mRNA Purification Kit (Pharmacia LKB Biotechnology, Piscataway, N J) according to the manufacturer's recommendation. Five micrograms of poly(A) RNA per lane were electrophoretically separated in a 1.5 % agarose gel containing 7% formaldehyde, and then blotted onto Hybond N+ nylon membrane filter (Amersham) by microcapillary transfer. Phosphate-labeled double-stranded DNA probes specific for each transcript were generated using a Megaprime labeling kit (Amersham) and [c~-32P] deoxycytidine 5'-triphosphate (Dupont). Hybridization was performed at 42°C, overnight, in a hybridizing solution consisting of 5 x SSPE, 0.1% sodium dodecylsulfate and 50% formamide, containing 5x Denhardt's solution and 100 txg/ml of denatured salmon sperm DNA as blocking reagents. Filters were then washed under stringent conditions (0.2x SSPE, 65°C, 30 min). Imaging was performed by autoradiography or the BAS2000 Imaging System (Fuji Film, Tokyo, Japan). The filters were routinely deprobed and rehybridized with other radioprobes.
The probes used in this study were as follows: for MyoD and myogenin, 3' noncoding HindlII-EcoRI and EcoRI-EcoRl fragments of the mouse cDNAs were used, respectively (Fujisawa et al., 1990) . In other cases, fragments were prepared by reverse transcriptase-PCR from cDNA prepared from C2C12 total RNA primed with random hexanucleotides, subsequently subcloned and sequenced. Primers used for PCR amplification were described in Hannon et al. (1992) for myf-5; G3PDH primers were purchased from Clontech Co. (Palo Alto, CA) (Arcari et al., 1984) ; MCK primers were CCACAGACAAGCATAAGACCGACC (position 377-401) and AACCTCCTTCATATTGCCTCCCI'FC (position 819-795), (Buskin et al., 1985) . Id primers were CACTCTGTI'CTCAGCCTCCTC (position 39-59) and GGCTGGAGTCCATCTGGTCCCT (position 567-546) (Benezra et al., 1990) .
LPA Quantitation in Serum Samples
Total lipids were extracted from the samples by the method of Bligh and Dyer after acidification with hydrogen chloride to pH 2.5 (Bligh and Dyer, 1959; Tokumura et al., 1994) , and subjected to a two-dimensional thin layer chromatography system using a silica gel 60 coated plate (Merck). The solvents used were chloroform/methanol/20% ammonium hydroxide (60:35:8, vol/vol/vol) for the first, and chloroform/acetone/methanol/acetic acid/water (6:8:2:2:1, vol/vol/vol/vol/vol) for the second dimensional development (Tokumura et al., 1994; Tigyi and Miledi, 1992) . Phospholipids were made visible by spraying with Dittmer-Lester reagent, and color intensities of the LPA spots were measured against the standard LPA using Atto Densitograph (Atto, Tokyo, Japan).
Results
Mitogenic and Anti-Differentiation Activities of LPA
To assess the effects of LPA on myoblasts, we used a serum-free condition where C2C12 mouse myoblast cells (Yaffe and Saxel, 1977; Blau et al., 1983) , withdrew from the cell cycle and underwent differentiation. When C2C12 cells were cultured in serum free ITS medium (containing insulin, transferrin, and selenite, see Materials and Methods), they differentiated and fused to form multinucleated myotubes within three days (Fig. 1, A-a) . Addition of L P A (10 i~g/ml) to the medium markedly suppressed myotube formation ( Fig. 1, A-b ), creatine kinase (CK), and troponin T expression (data not shown). The same results were obtained when bFGF (10 ng/ml) or FCS (10%) was added to the medium (Fig. 1 , A-c and e). Time course of the proliferation (indexed by number of nuclei) and differentiation (indexed by fusion index) of C2C12 cells in the presence of L P A or bFGF was examined (Fig. 1 , B and C, respectively). In ITS medium, cells ceased to proliferate and differentiated to form myotubes by culture day three. In the presence of L P A or bFGF they continued to proliferate and did not form multinucleated myotubes during the same culture period. A bromodeoxyuridine (BrdU) incorporation experiment (Fig. 1 D) showed that L P A and bFGF stimulated D N A synthesis in a way that corresponds to the growth rates shown in Fig. 1 B. On the basis of these observations, we conclude that LPA, as well as bFGF, can stimulate the proliferation and inhibit the differentiation of C2C12 myoblasts.
LPA Activities Are Specific among Structurally Related Lipids
The C2C12 cells cultured in DMEM containing 10% FCS were seeded onto collagen coated 24-well cell culture plates at the density of 104 cells/well. 24 h later the medium was switched to ITS medium (a) or ITS supplemented with LPA (10 ixg/ml, b), bFGF (10 ng/ml, c), LPA plus bFGF (10 Ixg/ml and 10 ng/ml, respectively, d) or FCS (10%, e). After 3 d in culture with daily medium changes, the cells were fixed and Giemsa-stained. Bar represents 100 ixm. on C2C12 myoblasts were examined. As shown in Fig. 2 A, the growth promoting and anti-differentiation activities of the lipids examined were limited to LPA and phosphatidic acid (PA), suggesting that LPA functions as a bioactive ligand. This is compatible with the previously described functions of LPA (van Corven et al., 1989; Jalink et al., 1990; van Corven et al., 1993; Jalink et al., 1993) . PA has been revealed to have similar effects to LPA in other systems (van Corven et al., 1989; Jalink et al., 1990) , actually due to LPA which was present as a contaminant or a degradation product of PA. Indeed, we detected a significant amount (5-10%) of LPA contaminated in our PA samples (data not shown). Therefore, it may be that the PA activities revealed here are also due to the contaminated LPA.
Dose-Response Profiles
As shown in Fig. 2 B, LPA stimulated growth and inhibited differentiation in a dose-dependent manner, and its effective concentration was higher than 1 I~g/ml (2.3 I~M). This is about the same dose required to evoke certain cellular responses including DNA synthesis in fibroblasts (van Corven et al., 1989 (van Corven et al., , 1993 . Throughout this study, we used 10 ~g/ml as the standard concentration of LPA, because higher concentrations (20-50 t~g/ml) sometimes caused cell lysis. Indeed, myogenic differentiation, indicated by fusion index (Fig. 2 , B-a) and CK activity (data not shown), was almost completely blocked at 10 txg/ml, indicating that this concentration provides almost full LPA activity. In case of bFGF, the dose-response properties were essentially the same as previously reported (Fig.   2 , B-b and d, Clegg et al., 1987) . The concentration of bFGF was fixed at 10 ng/ml.
Cooperative Effects of LPA and bFGF
We tested the proliferation and differentiation of C2C12 cells when both LPA and bFGF were added. Fig. 2 , C-a
shows that mitogenic effect of the simultaneous addition of the two agents is stronger than the separate effects of each agent. BrdU incorporation experiments provided essentially the same results (data not shown). Such a cooperative effect is also observed in the inhibition of differentiation indicated by the expression of the terminal differentiation markers (discussed later in Fig. 4 
LPA but Not bFGF Functions through Gi Proteins
In a number of systems, LPA evokes a wide variety of cellular responses through a putative cell surface receptor(s) coupled to G proteins (Moolenaar, 1994 (Moolenaar, , 1995 . Some of them are blocked by pertussis toxin (PT), indicating the involvement of Gi proteins, while others are mediated by other classes of G proteins and are resistant to PT (van Corven et al., 1989; Ridley and Hall, 1994) . We, therefore, investigated the PT sensitivities of LPA in our system to test the possible involvement of Gi (Fig. 3) . The growth stimulatory and differentiation inhibitory effects of LPA (indexed by myogenin expression here) were canceled by the presence of PT in the culture at concentrations above 5-10 ng/ml (Fig. 3) , indicating that LPA actions are mediated by Gi proteins. This data agrees with previous observations that the mitogenic activity of LPA in fibroblasts is PT-sensitive (van Corven et al., 1989 , 1993 . In contrast, the effects of bFGF were not affected by PT at any concentration tested; this result was expected because FGF receptor tyrosine kinases do not usually activate Gi proteins (Fantl et al., 1993; Jaye et al., 1992) . The growth stimulation and differentiation inhibition by FCS were also repressed by PT as reported by others (Kelvin et al., 1989a,b; Salminen et al., 1991) . Judging from these results, we conclude that LPA stimulates growth and suppresses differentiation of C2C12 myoblasts by a Gi-mediated mechanism(s), whereas hFGF's effects are independent of Gi proteins.
Differential Regulation of Myogenic bHLH Factors and Id
To address the target of the anti-differentiation activity of LPA, we examined the expression of myogenic bHLH factors. Series of investigations have revealed the roles of these factors which control myogenic determination and differentiation (for reviews see Weintraub, 1993; Olson and Klein, 1994) . MyoD and/or myf-5 are expressed in proliferating myoblasts and are involved in their maintenance, while myogenin plays important roles when the cells decide to withdraw from the cell cycle and differentiate Rudnicki et al., 1992 Rudnicki et al., , 1993 Nabeshima et al., 1993; Hasty et al., 1993) . MRF4 may be important in the later steps of differentiation.
In culture medium containing 10% FCS, the majority of our C2C12 cells expressed MyoD protein and mRNA (identical to the results from ITS plus 10% FCS shown in Fig. 4, A-e, B, and C) . When they were switched to bFGF medium, both MyoD protein and mRNA were dramatically reduced (Fig. 4, A-c, B , and C), as observed by Vaidya et al. (1989) . In contrast, in LPA medium, the proliferating myoblasts expressed significant levels of MyoD protein and mRNA (Fig. 4, A-b, B, and C) . Unlike MyoD, myf-5 mRNA was expressed at a relatively constant but low level under all the mitogenic conditions (Fig. 4 C) . The expression of myogenin and MCK was strongly induced upon differentiation in ITS medium, but greatly suppressed under all the mitogenic conditions. The coexistence of LPA and bFGF caused a greater suppression of MCK and myogenin expression, suggesting some concerted effects of the two factors. MRF-4 mRNA could not be detected in any of the conditions tested (data not shown).
We conclude that LPA-and bFGF-stimulated growth and inhibition of differentiation of C2C12 cells occur in distinct manners that result in two modes of myogenic bHLH factor expression: LPA mainly results in MyoD positive, myf-5 positive, and myogenin negative cells, while bFGF mainly results in MyoD negative, myf-5 positive, and myogenin negative cells. These two modes in C2C12 cells can be reversed by switching the LPA medium to bFGF medium, and vice versa (data not shown).
We also examined the expression of the Id gene, which encodes an HLH factor which lacks the basic region and inhibits the MyoD family and other bHLH factors (Benezra et al., 1990) duced to differentiate in ITS, Id level decreased dramatically (Fig. 4 c) , a result consistent with previous observation (Benezra et al., 1990) . When C2C12 cells were kept undifferentiated in the presence of L P A and/or bFGF, Id m R N A levels were significantly lower than in FCS and comparable to that in ITS (Fig. 4 C) , indicating that Id is unlikely to play a major role in LPA-and bFGF-induced differentiation inhibition.
Distinct Differentiation Potentials in Response to
Cell-Cell Contact
LPA and bFGF also differ in their effects on C2C12 cells when the cells are cultured to confluence. It has been known that C2C12 myoblasts grown in a media containing high concentration of serum spontaneously differentiate to produce myotubes after reaching confluence. Similarly, C2C12 cells grown to confluence in L P A differentiated and formed large myotubes that expressed Troponin T (Fig. 5, A-b and e) . Under these conditions, myogenin and MCK m R N A s were also expressed at high levels (Fig. 5  B) . In contrast, confluence-induced differentiation was dramatically suppressed by bFGF; only small myotubes incorporating a few nuclei were formed (Fig. 5, A-c) , and the expression of myogenin and MCK were very low (Fig. 5  B) . The inhibition of differentiation caused by bFGF was augmented when L P A and b F G F were added simultaneously; only a small population of mononucleated cells (<0.1%) became positive for Troponin T (Fig. 5, A-d) , and, myogenin and MCK m R N A expression were suppressed to an almost undetectable level (Fig. 5 B) . In contrast to L P A or FCS, b F G F downregulated MyoD in confluent cultures. Unlike M y o D or myogenin, the expression of myf-5 transcripts was less influenced by these extracellular signals (Fig. 5 B) .
These results suggest that L P A and b F G F each affect proliferating myoblasts differently in such a manner that results in distinct modes in their expression pattern of myogenic b H L H factors and results in different competence for differentiation in response to cell-cell contact.
Contribution of LPA to Serum Activities
As described above, L P A shares a number of properties with serum, which lead us to evaluate its contribution to serum activities. We measured the L P A amount in our se rum sample to be ~1.8 p,g/ml (4.1 ~M). This is consistent with other groups' previous reports (Eichholtz et al., 1993; Tokumura et al., 1994) and within the effective range for eliciting the growth-promoting and differentiation-inhibiting effects on C2C12 cells that we have demonstrated (Fig. 2 B) .
We then examined the activities of platelet poor plasmaderived serum (PPP). To generate PPP, platelets, which release the majority of serum LPA when activated upon clotting (Eichholtz et al., 1993) , were removed before clotting. Thus, PPP contains reduced quantities of LPA while retaining most other serum components. Indeed, we identified the concentration of LPA in PPP to be 0.19 i~g/ml (0.44 ~M), one tenth that found in FCS. We found that PPP possesses some growth-promoting and differentiation-inhibiting activities, but these activities are weaker than those found in FCS (Fig. 6 A) , and that addition of LPA to PPP strengthens both activities (Fig. 6 B) . Moreover, we also observed that addition of suramin, an LPA antagonist (van Corven et al., 1992) inhibits these serum activities (data not shown), although it must be noted that suramin can antagonize not only LPA but a broad spectrum of ligands (Coffey et al., 1987) . Altogether, these resuits suggest that LPA is one of the components of serum that contribute to the control of growth and differentiation of myoblast cells.
Discussion
LPA Has Mitogenic and Anti-Differentiation Effects on Myoblasts
We have demonstrated the mitogenic and differentiationinhibiting actions of LPA on C2C12 myoblasts. Among the wide variety of biological activities of LPA reported (for reviews see Moolenaar, 1994 Moolenaar, , 1995 , this study is the first report to show that LPA controls both cell growth and dif- Growth-promoting (a) and differentiation-inhibiting (b) activities of FCS and platelet poor plasma-derived serum (PPP). After C2C12 cells were cultured as described in Fig. 1 in the ITS medium containing titrated concentrations of FCS or PPP for 3 d with the daily changes of medium, the resulting total number of nuclei (a) and fusion index (b) were determined. LPA contents in these FCS and PPP samples were 1.8 txg/ml and 0.19 i.Lg/ ml, respectively. (B) Addition of LPA to PPP raised its growth-promoting and differentiation-inhibiting activities. C2C12 cells were cultured and subjected to total nuclei number and fusion index determination, in the ITS medium containing indicated concentrations of PPP in the presence or absence of LPA (10 ~zg/ml). Each data point is represented as the mean -4-SEM of three determinations.
ferentiation. We also demonstrated that LPA actions were structure-specific and dose dependent. Both properties agree with previous studies indicating that LPA acts, through cell surface receptor(s), as a bioactive ligand (van Corven et al., 1989 (van Corven et al., , 1992 Jalink et al., 1990) . LPA can elicit a variety of cellular responses, most of which are evoked by nanomolar concentrations of LPA, including Ca 2+ mobilization (Jalink et al., 1990 ) and the formation of focal adhesions/actin stress fibers Hall, 1992, 1994) . Because LPA-binding sites with kD on the nanomole order were detected in the membranes of Swiss 3T3 fibroblasts and rat brain (Thomson et al., 1994) , it seems reasonable that LPA evokes these responses through activating this putative LPA receptor. But, in contrast, micromolar doses are required for the mitogenic action of LPA on fibroblasts (van Corven et al., 1989 (van Corven et al., , 1993 , and we figured out that mitogenic and anti-differentiation effects of LPA on myoblasts also require micromolar concentrations of LPA (Fig. 2 B) . Intracellular signaling pathways leading to cell proliferation or differentiation inhibition might be activated only by higher concentrations of LPA through unidentified cell surface receptor(s). Alternatively, since these responses take long periods lasting for hours to days, LPA could be degraded and the actual concentration might be reduced as observed by van der Bend et al. (1992b) . Further investigations are needed to clarify this issue.
Gi-mediated LPA and RTK-mediated bFGF Inhibit the Differentiation by Distinct Mechanisms
Both growth-promoting and differentiation-inhibiting signals activated by LPA are blocked by PT, indicating the involvement of Gi proteins. On the other hand, bFGF is known to act through cell surface RTKs (for reviews see Fantl et al., 1993; Jaye et al., 1992) . Thus, C2C12 myoblasts have proved to be controlled by two distinct classes of mitogens; the Gi-and RTK-mediated mitogens. Such dual control of Gi-and RTK-mediated mitogens has been offered by others: thrombin and FGF on lung fibroblasts, and bombesin and PDGF on Swiss 3T3 fibroblasts (Chambard et al., 1987; Pouyssegur and Seuwen, 1992; Letterio et al., 1986) . Those investigations demonstrated that both mitogens induce proliferation and early response gene expression in fibroblastic cells, but were unable to clarify a qualitative difference between these mitogens.
Our results provide an evidence that actions of these Giand RTK-mediated mitogens are different in the control of the transcription network composed of the MyoD family of bHLH proteins; the MyoD gene is transcriptionally active in LPA-stimulated cells, but not in bFGF stimulated cells (Fig. 7) . Upon terminal differentiation process, MyoD protein can transactivate the myogenin gene, without requiring de novo protein synthesis, which is considered to be among the earliest and the most important events in this process (Hollenberg et al., 1993) . In the nuclei of the C2C12 cells proliferating in LPA, the MyoD protein is present but the myogenin gene is not activated (Fig. 4) . Therefore, LPA must activate mechanisms that inhibit MyoD from activating the myogenin gene. The target of bFGF is different in that it inhibits the expression of MyoD at the transcriptional level (Fig. 5; and Vaidya et al., 1989) . Coexistence of LPA and bFGF results in the suppression of MyoD, the bFGF-type phenotype (Fig. 4) , suggesting that the action of bFGF dominates that of LPA, as shown in Fig. 7 .
LPA and bFGF Proliferate the C2C12 Cells as Myoblasts
It should be mentioned that both LPA and bFGF proliferate the C2C12 cells with the myogenic potential maintained. Both the cells grown in LPA and/or bFGF were positive for Desmin, a marker for myogenic lineage; and they underwent differentiation to form myotubes when deprived of these factors (Yoshida, S., unpublished data). Considering that MyoD is expressed in LPA-stimulated cells but not in bFGF-stimulated cells, and that myf-5 is expressed in both cells (Fig. 4) , we postulate that myf-5 plays an essential role to maintain the myogenic potential of the proliferating myoblasts, especially in the presence of bFGF. On the other hand, MyoD might play a role in maintaining the cells in a proliferating but ready-to-differentiate state to regulate the timing of terminal differentiation, in our in vitro system. Because myf-5 can activate the entire myogenic differentiation program in several nonmuscle cells and MyoD knock-out mice (Braun et al., 1989 , myf-5's activity to promote differentiation is inhibited in myoblasts growing in LPA or bFGF (Fig. 7) . We investigated the expression of Id, a negatively regulating HLH factor (Benezra et al., 1990; Jen et al., 1992) , because it would throw light on the mechanism(s) with which LPA and bFGF keep the cells undifferentiated (Fig.  4 C (Weintraub, 1993; Olson and Klein, 1994) . Gi, Gi class of G protein; TyK, protein tyrosine kinase activities associate with FGF receptors.
only comparable levels of Id mRNA to that in differentiating cells in ITS, suggesting that Id is not always required for the inhibition of terminal differentiation. Other proposed mechanisms for differentiation inhibition, including induction of early response gene products, Jun, Fos or Myc (Rahm et al., 1989; Lassar et al., 1989; Bengal et al., 1992; Li et al., 1992a; Falcone et al., 1985; Denis et al., 1987) , or activation of protein kinase C, which can phosphorylate and inhibit the function of myogenic bHLH factors (Li et al., 1992b) , could be involved. Further investigations are needed to solve this issue.
Differentiation Induced by Cell-Cell Contact
LPA and bFGF provide the C2C12 cells with distinct differentiation potentials in response to cell-cell contact; differentiation induced by cell-cell contact was inhibited by bFGF, but not by LPA. These findings suggest that intracellular signals activated by cell-cell contact, whose nature remains to be understood, can dominate the LPA signaling pathways that lead to growth stimulation and differentiation inhibition; but they do not affect, or are repressed by, signals activated by bFGF. Downregulation of the LPA receptors might be involved here since LPA binding ability has been shown to decrease in confluent cultures of Swiss 3T3 cells (Thomson et al., 1994) . Investigations are still needed to reveal the mechanisms underlying these phenomena.
Contribution of LPA to Serum Activities
LPA is contained in serum (Eichholtz et al., 1993; Tokumura et al., 1994) and was detected in a significant amount in our serum preparation. Then, we examined its contribution to the serum mitogenic and anti-differentiation activities, to determine if it can fully substitute for serum. We observed that PPP, which contained one tenth the LPA of FCS, had much lower activities than FCS in growth-promotion and differentiation-inhibition of myoblasts, and that addition of LPA to PPP increased these activities (Fig. 6) . Moreover, suramin, an antagonist of LPA, repressed these effects of FCS (Yoshida, S., unpublished results). These findings support the idea that LPA is one of the serum components acting in its growth promotion and differentiation inhibition of myoblasts. It is clear that LPA is not the only component responsible to the mitogenic and anti-differentiation actions of serum; the mitogenic activity of LPA, indexed by growth rate and BrdU incorporation, was significantly lower than that of serum in our study (Fig. 1) . In addition, PT treatment was unable to completely inhibit the actions of serum (Fig. 3) , and PPP promoted growth and inhibited differentiation to smaller extent than FCS (Fig. 6) . Moreover, induction of Id requires serum component(s) other than LPA (Fig. 4) . These indicate that a component(s) other than LPA is also involved in the growth-stimulating and differentiation-inhibiting effects of serum.
Possible Roles In Vivo
LPA is thought to play an important role in wound healing and tissue regeneration because it is released by activated platelets upon clotting (Eichholtz et al., 1993; Tigyi and Miledi, 1992) , and evokes a number of responses which seem to be important for wound repairing (discussed in Moolenaar, 1995) . We and others (Eichholtz et al., 1993; Tokumura et al., 1994) have actually detected sufficient concentrations of LPA in serum to evoke mitotic response in myoblasts in vitro, indicating that platelets are capable of producing such high concentration of LPA upon clotting. Therefore, LPA might be involved in muscle regeneration; LPA is likely to be produced in the damaged muscle as a result of blood clotting and inflammation, and might stimulate the proliferation of resting myoblasts, the satellite cells, which is an initial and indispensable event for muscle regeneration (Allbrook, 1981) . It is possible that LPA is also involved in embryonic myogenesis. Indeed, we have observed that LPA can stimulate the growth of L6 embryonic myoblast cells (Yoshida, S., unpublishedresults). The distribution of LPA and the LPA receptor, which has yet to be cloned during development, should be investigated to know whether LPA plays a role in embryonic myogenesis.
FGF has also been suggested to be involved in both muscle regeneration and embryonic myogenesis (JosephSilverstein et al., 1989; Gonzalez et al., 1990; Guthridge et al., 1992; Anderson et al., 1991) . We speculate that if myoblasts are under the dual regulation of LPA and FGF, the distinct reactivities of LPA and bFGF to cell-cell contact would play an important role in the coordinated growth and differentiation of myoblasts; in the earlier stage of muscle formation, myoblasts might be required to proliferate to expand their population even in the differentiation promoting environment created by, for example, cell--cell contact, bFGF could provide myoblasts with this power. In later stages, on the other hand, myoblasts might have to proliferate with high differentiation potentials, preparing for timed growth arrest and terminal differentiation in response to extracellular cues. Myoblasts cultured in LPA might illustrate these properties in vitro.
